An observational study of the association between microalbuminuria and increased N-terminal pro-B-type natriuretic peptide in patients with subarachnoid hemorrhage

被引:3
|
作者
Terao Y. [1 ]
Oji M. [1 ]
Toyoda T. [1 ]
Inoue H. [1 ]
Fukusaki M. [1 ]
Hara T. [2 ]
机构
[1] Nagasaki Rosai Hospital, Department of Anesthesia, 2-12-5 Setogoe, Sasebo
[2] Nagasaki University School of Medicine, Department of Anesthesiology, 1-7-1 Sakamoto, Nagasaki
关键词
B-type natriuretic peptide; Microalbuminuria; N-terminal pro-B-type natriuretic peptide; Neurological outcome; Subarachnoid hemorrhage;
D O I
10.1186/s40560-015-0108-1
中图分类号
学科分类号
摘要
Background: The urinary albumin/creatinine ratio (ACR) is a significant neurologic prognostic predictor in patients with aneurysmal subarachnoid hemorrhage (SAH). B-type natriuretic peptide (BNP) plays an important role in body fluid regulation in patients with SAH. The present study was performed to determine whether ACR was independent predictor for unfavorable neurological outcome and ACR was associated with increased N-terminal pro-BNP (NT-pro-BNP) after SAH. Methods: We studied 61 patients undergoing surgery who were admitted within 48 h after aneurysmal SAH onset between July 2008 and June 2010. Hunt and Hess grade and Fisher grade were recorded at admission. The Glasgow Coma Scale (GCS) score was calculated at admission and daily for seven postoperative days. Arterial blood was sampled at admission and for seven postoperative days to determine the PaO2/FIO2 ratio, C-reactive protein level, troponin I level, and NT-pro-BNP level. Urine was sampled at admission and daily for seven postoperative days to determine ACR and vanillylmandelic acid/creatinine ratio (VMACR). Neurological outcomes were assessed at hospital discharge by using the Glasgow Outcome Scale. Receiver operating characteristic curves were constructed for the predictive variables of unfavorable neurological outcomes, and the area under the curve (AUC) was determined. Multivariate logistic regression analyses were performed for the significant predictors of unfavorable neurological outcomes after SAH. Associations with NT-pro-BNP were evaluated by using the Spearman rank correlation test. Results: Of the 61 patients, 24 had unfavorable outcomes. The prevalence rate of microalbuminuria was 85 % (52/61). The highest NT-pro-BNP levels were above the normal range in 57 of 61 patients (93 %). According to the AUC, the Hunt and Hess grade, GCS score, the highest ACR, and highest VMACR were significant predictors of neurological outcome. Multivariate logistic regression analyses showed that the highest ACR and Hunt and Hess grade are independent prognostic predictors of unfavorable neurological outcomes. The highest NT-pro-BNP significantly correlated with the highest troponin I, highest ACR, and VMACR on admission. Conclusions: The highest ACR is an independent prognostic predictor of unfavorable neurological outcomes after SAH. Moreover, plasma NT-pro-BNP elevation may be associated with the development of microalbuminuria. © 2015 Terao et al.
引用
收藏
相关论文
共 50 条
  • [1] ASSOCIATION OF HEART RATE WITH N-TERMINAL PRO-B-TYPE NATRIURETIC PEPTIDE IN SEPTIC PATIENTS: A PROSPECTIVE OBSERVATIONAL COHORT STUDY
    Hayase, Naoki
    Yamamoto, Miyuki
    Asada, Toshifumi
    Isshiki, Rei
    Yahagi, Naoki
    Doi, Kent
    SHOCK, 2016, 46 (06): : 642 - 648
  • [2] N-terminal Pro-B-Type Natriuretic Peptide and Malnutrition in Patients on Hemodialysis
    Ducros, Jacques
    Larifla, Laurent
    Merault, Henri
    Galantine, Valerie
    Bassien-Capsa, Valerie
    Foucan, Lydia
    INTERNATIONAL JOURNAL OF NEPHROLOGY, 2020, 2020
  • [3] N-terminal pro-B-type natriuretic peptide is also related to increased mortality
    Golcuk, Yalcin
    Golcuk, Burcu
    Sozen, Semih
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2015, 33 (05): : 729 - 730
  • [4] N-Terminal Pro-B-Type Natriuretic Peptide and Clinical Outcomes
    Ezekowitz, Justin A.
    O'Connor, Christopher M.
    Troughton, Richard W.
    Alemayehu, Wendimagegn G.
    Westerhout, Cynthia M.
    Voors, Adriaan A.
    Butler, Javed
    Lam, Carolyn S. P.
    Ponikowski, Piotr
    Emdin, Michele
    Patel, Mahesh J.
    Pieske, Burkert
    Roessig, Lothar
    Hernandez, Adrian F.
    Armstrong, Paul W.
    JACC-HEART FAILURE, 2020, 8 (11) : 931 - 939
  • [5] N-Terminal Pro-B-Type Natriuretic Peptide and Incident CKD
    Sasaki, Takaya
    Oishi, Emi
    Nagata, Takuya
    Sakata, Satoko
    Chen, Sanmei
    Furuta, Yoshihiko
    Honda, Takanori
    Yoshida, Daigo
    Hata, Jun
    Tsuboi, Nobuo
    Kitazono, Takanari
    Yokoo, Takashi
    Ninomiya, Toshiharu
    KIDNEY INTERNATIONAL REPORTS, 2021, 6 (04): : 976 - 985
  • [6] The relation between N-terminal pro-B-type natriuretic peptide and heart failure
    Balta, Sevket
    Demirkol, Sait
    Kucuk, Ugur
    Unlu, Murat
    Arslan, Zekeriya
    Celik, Turgay
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2013, 31 (10): : 1533 - 1533
  • [7] N-Terminal Pro-B-Type Natriuretic Peptide Variability in Stable Dialysis Patients
    Fahim, Magid A.
    Hayen, Andrew
    Horvath, Andrea R.
    Dimeski, Goce
    Coburn, Amanda
    Johnson, David W.
    Hawley, Carmel M.
    Campbell, Scott B.
    Craig, Jonathan C.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2015, 10 (04): : 620 - 629
  • [8] N-TERMINAL PRO-B-TYPE NATRIURETIC PEPTIDE IN PATIENTS WITH HYPERTENSIVE HEART DISEASE
    Pejovic, Janko
    Ignjatovic, Svetlana
    Dajak, Marijana
    Majkic-Singh, Nada
    Vucinic, Zarko
    JOURNAL OF MEDICAL BIOCHEMISTRY, 2011, 30 (03) : 244 - 249
  • [9] N-terminal pro-B-type natriuretic peptide in patients with growth hormone disturbances
    Andreassen, Mikkel
    Faber, Jens
    Vestergaard, Henrik
    Kistorp, Caroline
    Kristensen, Lars Ostergaard
    CLINICAL ENDOCRINOLOGY, 2007, 66 (05) : 619 - 625
  • [10] N-TERMINAL PRO-B-TYPE NATRIURETIC PEPTIDE LEVEL IN TYPE 2 DIABETIC PATIENTS
    Vasilkova, Volha
    Mokhort, Tatiana
    Zmailik, Margarita
    Naumenko, Elena
    JOURNAL OF HYPERTENSION, 2016, 34 : E438 - E438